alexa Ocular Melanin Modulates Pharmacokinetics And Drug Disposition Of Therapeutic Agents
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Viral Kansara, John Reilly, Cornelia Forster, Ann Brown, Jakal Amin, Timothy Drew and Bruce Jaffee
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
OMelanin is a heterogeneous biopolymer which is present in the front and back of the eye. Due to its acidic and hydrophobic nature, many therapeutic agents bind to melanin-rich ocular tissues such as the iris-ciliary body, choroid and retinal pigment epithelium of the eye. We hypothesized that drugs with high affinity to melanin are linked to higher ocular exposure, with melanin postulated to be a potential depot for such compounds. To test this hypothesis, in vivo ocular and plasma pharmacokinetic (PK) studies of three compounds with high, medium and low melanin affinity were performed in pigmented and non-pigmented rats. Male Sprague-Dawley (non-pigmented) and Brown-Norway (pigmented) rats were used to determine ocular and plasma PK of selected compounds. The PK parameters were determined using Watson LIMS (Non-compartmental analysis). Using a high-throughput chromatography based in vitro assay, we screened 306 compounds of diverse chemical structures for their in vitro melanin affinity (67 ? low-; 168 ? medium-; 71 ? high- affinity). In our in vivo studies, a significant increase in ocular exposures of high affinity (AUCPEC: 73?M*h vs. 2?M*h; AUCretina: 8 ?M*h vs. 3?M*h) and medium affinity (AUCPEC: 9?M*h vs. 0.6?M*h; AUCretina: 6?M*h vs. 2.6?M*h) compounds were observed in pigmented rats compared with non-pigmented rats. The increased ocular exposure (in vivo) correlated with increased retention time on the chromatography (in vitro) method. This vitro assay wasshown to be predictive of in vivo melanin dependent ocular compound deposition. This approach provided excellent in-vitro-in-vivo correlations(IVIVC). In conclusion, this research suggests that ocular melanin affinity modulates ocular PK and drug retention in the eye, and may influence the pharmacological action of ocular targeted therapeutic agents.
Biography
Viral Kansara is the Investigator at the Novartis Institutes for Biomedical Research. He leads Ocular Pharmacokinetics and Drug Delivery laboratory within Pharmacology group. His team focuses on discovery and development of novel targets and delivery systems to treat AMD, diabetic retinopathy and glaucoma. Viralearned his Ph.D. in the field of Pharmaceutical Sciences from Ashim Mitra?s Laboratory at the University of Missouri-Kansas City. He has authored 2 book chapters and numerous research articles in reputed journals and has been serving as a reviewer for PharmRes, IOVS, AAPS PharmSciTech, and JOPT.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version